Latest debt-to-equity ratio
Acrivon Therapeutics Debt-to-equity ratio
Direct answer
Acrivon Therapeutics's debt-to-equity ratio is 2.44%.
The verified market snapshot reports 2.44%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 22, 2026.
Get free Acrivon Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.44%
Explore related company data
View Acrivon Therapeutics's market capitalizationView Acrivon Therapeutics's price-to-book ratioView Acrivon Therapeutics's return on equityView Acrivon Therapeutics's dividend yieldView Acrivon Therapeutics's 52-week price rangeView Acrivon Therapeutics's profit marginView all Acrivon Therapeutics key metricsReturn to Acrivon Therapeutics profile